0001453687-23-000092.txt : 20231201
0001453687-23-000092.hdr.sgml : 20231201
20231201164308
ACCESSION NUMBER: 0001453687-23-000092
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20231201
DATE AS OF CHANGE: 20231201
EFFECTIVENESS DATE: 20231201
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cartesian Therapeutics, Inc.
CENTRAL INDEX KEY: 0001453687
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-498655
FILM NUMBER: 231460175
BUSINESS ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-923-1400
MAIL ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: SELECTA BIOSCIENCES INC
DATE OF NAME CHANGE: 20090109
D
1
primary_doc.xml
X0708
D
LIVE
0001453687
Cartesian Therapeutics, Inc.
704 Quince Ochard Road
Gaithersburg
MD
MARYLAND
20878
617-923-1400
DELAWARE
SELECTA BIOSCIENCES INC
Corporation
true
Carsten
Brunn
704 Quince Ochard Road
Gaithersburg
MD
MARYLAND
20878
Executive Officer
Blaine
Davis
704 Quince Ochard Road
Gaithersburg
MD
MARYLAND
20878
Executive Officer
Carrie
S.
Cox
704 Quince Ochard Road
Gaithersburg
MD
MARYLAND
20878
Director
Timothy
Barabe
704 Quince Ochard Road
Gaithersburg
MD
MARYLAND
20878
Director
Nishan
De Silva
704 Quince Ochard Road
Gaithersburg
MD
MARYLAND
20878
Director
Murat
Kalayoglu
704 Quince Ochard Road
Gaithersburg
MD
MARYLAND
20878
Director
Aymeric
S.
Sallin
704 Quince Ochard Road
Gaithersburg
MD
MARYLAND
20878
Director
Michael
Singer
704 Quince Ochard Road
Gaithersburg
MD
MARYLAND
20878
Director
Patrick
S.
Zenner
704 Quince Ochard Road
Gaithersburg
MD
MARYLAND
20878
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-11-13
false
true
convertible preferred stock convertible into common stock
true
0
60250000
60250000
0
false
2
0
0
0
false
Cartesian Therapeutics, Inc.
/s/ Blaine Davis
Blaine Davis
Chief Financial Officer
2023-12-01